- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Platinum Sensitive
Total 406 results
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Ovarian High Grade Serous Adenocarcinoma | Fallopian... and other conditionsUnited States, Puerto Rico
-
Atreca, Inc.TerminatedMelanoma | Breast Cancer | Hepatocellular Carcinoma | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Triple Negative Breast Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Urothelial Carcinoma | Acral Lentiginous Melanoma | Platinum-Resistant Fallopian... and other conditionsUnited States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedEndometriosis, Uterine Fibroids, Male Hormone-sensitive Prostate Cancer, Assisted ReproductionChina
-
WiSP Wissenschaftlicher Service Pharma GmbHClinAssess GmbHUnknown
-
OncoMed Pharmaceuticals, Inc.Completed
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's Hospital; National Comprehensive...CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Threshold PharmaceuticalsTerminatedCarcinoma, Small Cell LungUnited States
-
Lei LiUnknownEpithelial Ovarian Cancer | Homologous Recombination Deficiency | Prognosis | BRCA Mutation | Loss of Heterozygosity | Platinum ResistanceChina
-
Duke UniversityCompletedPalliative Care | Platinum-resistant Ovarian Cancer | Recurrent Ovarian CancerUnited States
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsGOG FoundationCompletedRecurrent Platinum Resistant Ovarian CancerUnited States, Israel, Japan, Poland, Spain
-
Cancer Institute and Hospital, Chinese Academy...Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingPlatinum-resistant Recurrent Ovarian CancerChina
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.CompletedRecurrent Platinum Resistant Ovarian CancerUnited States
-
Peking Union Medical College HospitalUnknownRecurrent Platinum-resistant Ovarian CancerChina
-
SanofiCompleted
-
National Cancer Institute, NaplesMario Negri Institute for Pharmacological ResearchActive, not recruitingRecurrent Ovarian CancerFrance, Italy, Switzerland, Monaco, Greece
-
Northwell HealthWithdrawnPolycystic Ovarian Syndrome (PCOS) | Patients Sensitive to Exogenous Gonadotropins | Ovarian Hyper Stimulation Syndrome (OHSS)United States
-
GlaxoSmithKlineCompletedOvarian Cancer | Neoplasms, OvarianUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Adenocarcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Advanced Pancreatic Adenocarcinoma | Platinum-Resistant... and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial Carcinoma | Stage III Uterine Corpus Cancer AJCC v8 | Stage IV Uterine Corpus Cancer AJCC v8 | Recurrent Platinum-Resistant Ovarian Carcinoma | Metastatic Fallopian Tube Carcinoma | Metastatic Primary... and other conditionsUnited States
-
SOTIO a.s.CompletedOvarian Cancer RecurrentCzechia
-
Laekna LimitedActive, not recruitingPlatinum-resistant Ovarian CancerUnited States, China
-
CureLab OncologyActive, not recruitingOvarian Cancer | Platinum-resistant Ovarian CancerBelarus
-
Xinhua Hospital, Shanghai Jiao Tong University...RecruitingPlatinum-resistant Recurrent Ovarian CancerChina
-
Yonsei UniversitySamsung Medical Center; AstraZeneca; Seoul National University Hospital; Korean... and other collaboratorsRecruitingPlatinum-resistant Recurrent Ovarian CancerKorea, Republic of
-
Peking University People's HospitalBeijing Weixiao Biotechnology Development LimitedRecruitingRecurrent Ovarian Carcinoma | Platinum-resistant Ovarian CancerChina
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...RecruitingRecurrent, Platinum-resistant Ovarian CancerItaly
-
Regeneron PharmaceuticalsSanofiCompletedSquamous Cell Carcinoma (SCC) | Recurrent or Metastatic, Platinum-refractory Cervical CancerSpain, Korea, Republic of, United States, United Kingdom, Taiwan, Brazil, Belgium, Australia, Italy, Canada, Japan, Greece, Poland, Russian Federation
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityZai Lab (Shanghai) Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedPlatinum-resistant Recurrent Clear Cell Ovarian CancerChina
-
ARCAGY/ GINECO GROUPPharmaMarCompletedOvarian CancerFrance
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube... and other conditionsUnited States
-
Sonnet BioTherapeuticsHoffmann-La RocheRecruitingAdvanced Solid Tumor | Platinum-resistant Ovarian CancerUnited States, Australia
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingPlatinum-Resistant Ovarian CarcinomaUnited States
-
Aravive, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...TerminatedPlatinum-resistant Ovarian CancerUnited States, Spain, Belgium, Canada, Georgia, Czechia, China, Poland, France, United Kingdom, Italy
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)TerminatedMaveropepimut-S (MVP-S) and Low-Dose CPA in Patients With Platinum-Resistant Ovarian Cancer (AVALON)Platinum-resistant Epithelial Ovarian CancerUnited States, Canada, Puerto Rico
-
xCuresTerminatedTransitional Cell Carcinoma | Bladder Cancer | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | FGFR2 Gene Mutation | FGFR3 Gene Mutation | FGFR2 Amplification | Bladder Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Refractory Bladder Carcinoma | Refractory Bladder Urothelial Carcinoma and other conditionsUnited States
-
AGO Study GroupPhilipps University Marburg Medical Center; HSK Reasearch GmbH WiesbadenCompletedPlatinum Refractory Epithelial Ovarian Cancer | Primary Cancer of the Peritoneum | Cancer of the Fallopian TubeGermany
-
Jonsson Comprehensive Cancer CenterAstraZenecaActive, not recruitingMetastatic Malignant Female Reproductive System Neoplasm | Platinum-Resistant Malignant Female Reproductive System Neoplasm | Recurrent Malignant Female Reproductive System Neoplasm | Refractory Malignant Female Reproductive System NeoplasmUnited States
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.CompletedRelapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityUnited States, Italy, Spain, Belgium, Poland, Canada, Korea, Republic of, Brazil, Czechia, Hungary, Israel, Argentina, Mexico
-
British Columbia Cancer AgencyRecruitingOvarian Cancer | Platinum-resistant Ovarian CancerCanada
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.TerminatedA Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed Ovarian CancerPlatinum-resistant Ovarian CancerChina
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, Pulmonary | Pulmonary Disease | Multi Drug Resistant Tuberculosis | Drug Sensitive Tuberculosis | Drug-resistant Tuberculosis | Mycobacterium Tuberculosis InfectionUnited States
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, Pulmonary | Pulmonary Disease | Multi Drug Resistant Tuberculosis | Drug Sensitive Tuberculosis | Drug-resistant Tuberculosis | Mycobacterium Tuberculosis InfectionUnited States
-
SOTIO a.s.CompletedOvarian Neoplasms | Ovarian Epithelial Cancer | Ovarian Cancer (OvCa)Czechia, Poland, Germany
-
Grupo Español de Investigación en Cáncer de OvarioPharmaMarCompleted
-
Stanford UniversityTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
Lei LiRecruitingRecurrent Ovarian Carcinoma | Platinum-resistant Ovarian Cancer | Bevacizumab | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Albumin-bound PaclitaxelChina
-
Sun Yat-sen UniversityHutchmedRecruitingOvarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal Cancer | Ovarian Carcinoma | Fallopian Tube CarcinosarcomaChina
-
Donna Hammond, PhDNational Cancer Institute (NCI); ChromaDex, Inc.TerminatedBreast Cancer Metastatic | Chemotherapy-induced Peripheral Neuropathy | Head and Neck Cancer Stage IV | Endometrial Cancer Stage IV | Platinum-resistant Recurrent Ovarian CancerUnited States
-
Cybrexa TherapeuticsNot yet recruitingPlatinum-resistant Ovarian Cancer | Refractory Ovarian Carcinoma
-
AstraZenecaCompletedOvarian CancerCanada, Czechia, Poland, Romania, United States, Belgium, France, Russian Federation, United Kingdom, Israel, Spain, Germany, Austria, Netherlands, Australia, Estonia, Ukraine